NORBERTO
ORTEGO CENTENO
CATEDRÁTICO DE UNIVERSIDAD
Complejo Asistencial Universitario de León
León, EspañaPublicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de León (20)
2023
-
Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 910-915
-
Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 864-869
2022
-
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases
International Journal of Technology Assessment in Health Care, Vol. 38, Núm. 1
-
Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review
Rheumatology (Oxford, England), Vol. 61, Núm. 11, pp. 4427-4436
-
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)
Autoimmunity Reviews, Vol. 21, Núm. 10
-
Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype
Clinical and experimental rheumatology, Vol. 40, Núm. 4, pp. 727-733
2021
-
HLA association with the susceptibility to anti-synthetase syndrome
Joint Bone Spine, Vol. 88, Núm. 3
-
Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome
Scientific Reports, Vol. 11, Núm. 1
-
The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis
Clinical and experimental rheumatology, Vol. 39, Núm. 2, pp. 21-26
2020
-
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
-
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135
-
Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases
Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 1, pp. 359-368
2018
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2013
-
Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition
BMC Medical Genetics, Vol. 14, Núm. 1
-
Lack of association between the protein tyrosine phosphatase non-receptor type 22 R263Q and R620W functional genetic variants and endogenous non-anterior uveitis
Molecular Vision, Vol. 19, pp. 638-643
-
No evidence of association between common autoimmunity STAT4 and IL23R risk polymorphisms and non-anterior uveitis
PLoS ONE, Vol. 8, Núm. 11
-
Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis
PLoS ONE, Vol. 8, Núm. 10
-
Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis
Mediators of Inflammation, Vol. 2013
2012
-
Treatment of refractory uveitis with adalimumab: A prospective multicenter study of 131 patients
Ophthalmology, Vol. 119, Núm. 8, pp. 1575-1581